Drospirenone intake alters plasmatic steroid levels and cyp17a1 expression in gonads of juvenile sea bass by Blanco, Maria et al.
lable at ScienceDirect
Environmental Pollution 213 (2016) 541e548Contents lists avaiEnvironmental Pollution
journal homepage: www.elsevier .com/locate/envpolDrospirenone intake alters plasmatic steroid levels and cyp17a1
expression in gonads of juvenile sea bass*
Maria Blanco a, Denise Fernandes a, b, Paula Medina c, d, Mercedes Blazquez c, **,
Cinta Porte a, *
a Environmental Chemistry Department, IDAEA-CSIC, Jordi Girona 18, 08034 Barcelona, Spain
b CIMA, University of Algarve, FCT, Campus de Gambelas, 8005-139 Faro, Portugal
c Instituto de Ciencias del Mar, ICM-CSIC, Passeig Maritim 37-49, 08003 Barcelona, Spain
d University of Antofagasta, Av. Angamos 601, Antofagasta, Chilea r t i c l e i n f o
Article history:
Received 12 November 2015
Received in revised form
26 February 2016
Accepted 2 March 2016
Available online 17 March 2016
Keywords:
Progestins
Sea bass
Sex steroids
Metabolism
cyp17a1* This paper has been recommended for acceptanc
* Corresponding author.
** Corresponding author.
E-mail addresses: blazquez@icm.csic.es (M. Blaz
(C. Porte).
http://dx.doi.org/10.1016/j.envpol.2016.03.007
0269-7491/© 2016 Elsevier Ltd. All rights reserved.a b s t r a c t
Drospirenone (DRO) is one of the most widely used progestins in contraceptive treatments and hormone
replacement therapies. The pharmacokinetics and potential toxicological effects of DRO were investi-
gated in juvenile sea bass (Dicentrarchus labrax) exposed through the diet (0.01e10 mg DRO/g) for up to
31 days. DRO was detected in the blood (4e27 ng/mL) of ﬁsh exposed to the highest concentration, with
no signiﬁcant bioaccumulation over time and no alteration of hepatic metabolizing enzymes, namely,
CYP1A and CYP3A-catalysed activities and UDP-glucuronyltransferase (UGT). Pregnenolone (P5), pro-
gesterone (P4), 17a-hydroxyprogesterone (17P4), 17a-hydroxypregnenolone (17P5), androstenedione
(AD) and testosterone (T) were determined in plasma and gene expression of cyp17a1, cyp19a1a and
cyp11b analysed by qRT-PCR in gonads. The signiﬁcant increase in plasmatic levels of 17P5, 17P4 and AD
detected after 31 days exposure to 10 ng DRO/g together with the increased expression of cyp17a1 in
females evidence the ability of DRO to alter steroid synthesis at low intake concentrations (7 ng DRO/
day). However, the potential consequences of this steroid shift for female reproduction remain to be
investigated.
© 2016 Elsevier Ltd. All rights reserved.1. Introduction
Drospirenone (DRO) (6b,7b,15b,16b-dimethylene-3-oxo-17a-
pregn-4-ene-21,17-carbolactone) is a newgeneration progestin and
a derivative of the synthetic mineralocorticoid 17a-spironolactone,
with a pharmacologic proﬁle similar to progesterone, and with
anti-mineralocorticoid, anti-aldosterone and slight antiandrogenic
activity (Krattenmacher, 2000; Rapkin and Winer, 2007). It is pre-
scribed in contraceptive treatments and hormone replacement
therapies in combinationwith estradiol or ethynilestradiol at doses
up to 150-fold higher than estrogens, and it is one of the most
widely used synthetic progestins in Europe (Fent, 2015). Thus,
environmental concentrations of DRO are expected to be in thee by Sarah Michele Harmon.
quez), cinta.porte@cid.csic.essame range or higher than other synthetic estroges and progestins,
which are detected at the low ng/L range in efﬂuents (Besse and
Garric, 2009). However, DRO and some other new generation pro-
gestins have not yet been extensively monitored in aquatic systems
(Fent, 2015).
In teleost ﬁsh, natural progestins play an important role in the
stimulation of oocyte growth and maturation as well as in sper-
matogenesis and sperm maturation, and they also act as sex
pheromones (Nagahama and Yamashita, 2008; Scott et al., 2010).
Moreover, ﬁsh possess similar drug targets as humans, and
consequently, synthetic progestins can interact with those
conserved targets and adversely affect reproduction (Runnalls et al.,
2013). Thus, levonorgestrel or gestodene at concentrations of
100 ng/L stopped spawning almost completely in the fathead
minnow; gestodene concentrations as low as 1 ng/L had signiﬁcant
effects on reproduction over 21 days, whereas desogestrel was less
potent, but still reduced egg production at concentrations of or
above 1 mg/L. Zeilinger et al. (2009) reported reduced fertility of
fathead minnow at concentrations of levonorgestrel as low as
M. Blanco et al. / Environmental Pollution 213 (2016) 541e5485420.8 ng/L and DRO of 6.5 mg/L, while reproductionwas not affected at
lower concentrations of DRO (100 ng/L) (Runnalls et al., 2013).
Additionally, norethindrone decreased fecundity in fathead
minnow and medaka, and levonorgestrel disrupted the seasonal
breeding cycle in male sticklebacks, both at concentrations in the
low ng/L range (Paulos et al., 2010; Svensson et al., 2014).
Despite of these evidences, the mechanisms which mediate
endocrine disruption by synthetic progestins are poorly under-
stood. Modulated gonadotropin expression in the pituitary and
changes of plasma sex steroid levels underlie many of the repro-
ductive effects, as reduced fecundity or disturbed gonad develop-
ment. However, the concentrations needed to induce changes in
steroid levels are usually higher than those to reduce fecundity
(Kumar et al., 2015). In vitro exposure of fathead minnow ovaries to
progesterone resulted in increased synthesis of pregnenolone, 17a-
hydroxyprogesterone, 17a,20b-dihydroxypregnenone and testos-
terone, while norethindrone had no signiﬁcant effect, despite a
non-signiﬁcant decrease of testosterone production (Petersen et al.,
2015). Interestingly, DRO inhibited CYP17 activity (metabolism of
17a-hydroxyprogesterone to androstenedione) in carp testis
mitochondrial fractions in vitro (IC50: 3.8 mM). DRO was a stronger
inhibitor than cyproterone acetate (IC50: 183 mM), while other
synthetic progestins (levonorgestrel and norethindrone) did not
affect CYP17 activity (Fernandes et al., 2014).
Progestins are shown to alter the expression of steroidogenic
enzymes in zebraﬁsh and fathead minnows (Overturf et al., 2014;
Fent, 2015). Transcriptional changes were generally more sensi-
tive than changes on steroid levels and revealed a number of
affected pathways, including steroid hormone receptor activities
and steroid hormone mediated signaling pathways, cellular
response to steroid hormone stimulus and thyroid hormone re-
ceptor activity (Zucchi et al., 2014). More recently, Zhao et al. (2015)
reported signiﬁcant and dose-dependent alterations of the circa-
dian rhythm network in the brain of zebra ﬁsh exposed to pro-
gesterone and DRO.
Within this context, the present study was designed to inves-
tigate the effect of DRO exposure in the hepatic metabolism (CYP1A
and CYP3A-catalysed activities and UDP-glucuronyltransferase
(UGT)), circulating steroid levels and expression of key steroido-
genic enzymes (cyp17a1, cyp19a1a, cyp11b) in gonads of juveniles of
European sea bass (Dicentrarchus labrax), with the aim of gathering
information on the dynamics and the mode of action of this syn-
thetic progestin in juvenile ﬁsh, in a period particularly sensitive to
the effect of exogenous steroids (Piferrer et al., 2005).
2. Material and methods
2.1. Chemicals
Drospirenone, p-nitrophenol (pNP), uridine 50-diphosphoglu-
curonic acid (UDPGA), NADPH, 7-ethoxyresoruﬁn (7-ER), bovine
serum albumin (BSA; fatty acid free,  99% purity), methyl tert-
butyl ether (MTBE) and hydroxylamine hydrochloride were pur-
chased from Sigma-Aldrich (Steinheim, Germany). D8-17-
hydroxyprogesterone (d8-17P4) was obtained from C/D/N Iso-
topes (Quebec, Canada); d9-progesterone (d9-P4), d4-
pregnenolone (d4-P5), d3-testosterone (d3-T), pregnenolone (P5),
progesterone (P4), 17-hydroxyprogesterone (17P4), 17- hydrox-
ypregnenolone (17P5), androstenedione (AD) and testosterone (T)
were obtained from Sigma-Aldrich (Steinheim, Germany). 7-
Benzyloxy-4-triﬂuoromethyl-coumarin (7-BFC) was from Cypex
(Dundee, Scotland, UK). Dulbecco's Phosphate Buffered Saline
(DPBS) was obtained from Gibco (Life technologies). Primers of
selected genes and SuperScript III Reverse Transcriptase were ob-
tained from Invitrogen. All solvents were from Merck (Darmstadt,Germany).
2.2. Experimental design
Juvenile European sea bass e 243 days post-hatching (dph)
(100e185 mm length) reared at the experimental animal facility of
the Institute of Marine Science (Barcelona, Spain), were randomly
distributed into six 50 L tanks (30 individuals per tank) for accli-
matization at a ﬂow rate of 1.2 L water/min with 80% oxygen
saturation, natural temperature (14.5e15 C) and photoperiod
(light:dark, 9:15). After the acclimatization period (4 weeks), ﬁsh
were fed with commercial pellets spiked with DRO at a concen-
tration of 0.01, 0.1, 1 and 10 mg/g, with a daily average intake of 0.7 g
of pellet feed per ﬁsh. The experimental diets were prepared
following the alcohol evaporation method adapted for the sea bass
(Blazquez et al., 1995). Brieﬂy, food pellets were sprayed with the
different concentrations of DRO dissolved in ethanol, being the
solvent completely evaporated afterwards. A solvent control (SC)
groupepellets only sprayed with ethanoleand a control group-
euntreated pellets-were also included in the study. The highest
concentrations (1 & 10 mg/g of DRO) corresponded to typical doses
of estrogens or androgens used in experiments of sex reversal in
this species (Blazquez et al., 1998, 2001), while concentrations of
0.01 and 0.1 mg/g are close to the human therapeutical dose
(0.05 mg/g of DRO).
Fish were sampled after 2, 4, 8, 16 and 31 days of exposure. They
were anesthetized with 0.2% phenoxyethanol and the individual
weights and lengths measured. Blood (approx. 1 mL) was taken
from the caudal vein, transferred into heparinised tubes, centri-
fuged (1000  g; 15 min), and the plasma separated and stored
at 80 C. Immediately after, ﬁsh were sacriﬁced by quickly
severing the spinal cord and the liver and the gonads were
dissected. A fragment of the central part of the left gonad from each
ﬁsh was separated and ﬁxed in 4% PAF (buffered para-
formaldehyde) for further histological analysis. The rest of the go-
nads and the liver were immediately frozen in liquid nitrogen and
stored at 80 C. All ﬁsh were treated in accordance with the
Spanish regulations (Royal Decree Act 53/2013) and the European
legislation (2010/63 EU) concerning the protection of vertebrates
used for experimental and other scientiﬁc purposes. All the steps
were taken to reduce suffering of the animals.
2.3. Analysis of drospirenone in plasma
Circulating levels of DRO in plasma were determined after 2, 4,
8,16 and 31 days of exposure to the highest concentration (10 mg/g).
Acetonitrile (400 mL) was added to 100 mL of plasma, centrifuged at
4000  g for 10 min and the resulting supernatant (10 mL) injected
in an UPLC-MS/MS system (Ultra Acquity LC System, TQ Detector,
Waters, USA). To determine extraction efﬁciency a known con-
centration of DRO was added to plasma of non-exposed individuals
and extracted as mentioned above. DRO was detected under posi-
tive electrospray ionization (ESþ) and multiple reaction mode
(MRM) measuring the transition of precursor ion fragmentation
(367m/z) to product ions (97/91m/z) under a collision energy of 41/
75 Ev and with a capillary voltage of 3.50 Kv and cone voltage of
40 V. The analysis was performed using a Zorbax Eclipse Plus C-18
column (2.1 mm  50 mm, 1.8 mm) (Agilent, Loveland, U.S) con-
nected to a pre-column Zorbax Eclipse Plus C-18 (2.1 mm  5 mm,
1.8 mm) (Agilent, Loveland, U.S) with a mobile phase composed of
acetonitrile (A) and Milli-Q water containing 0.1% (v/v) of formic
acid (B). The run consisted of 0.5 min at 25% A, a 8 min linear
gradient from25% A to 90% A, 2min at 90% A and back over to initial
state at 1 min, allowing 1 min for column re-equilibration. The total
run-time was 12 min at a ﬂow rate of 0.3 mL/min. The column was
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conditions, was of 4 min and the limit of detectionwas <1 mg/L. The
efﬁciency of the extraction procedure was of 98 ± 0.5% (n ¼ 6).
2.4. Plasma steroid analysis
Plasmatic steroid levels (i.e. pregnenolone (P5), progesterone
(P4), 17-hydroxyprogesterone (17P4), 17- hydroxypregnenolone
(17P5), androstenedione (AD) and testosterone (T)) were analysed
after 4 and 31 days of exposure. Plasma samples were extracted
according to the procedure described by Keski-Rahkonen et al.
(2011). 400 mL of plasma together with 10 mL of internal standard
(IS; mix solution of deuterated steroids) at 10 ppb was placed into
glass screw top tubes, vigorously mixed and extracted twice with
1 mL of MTBE after centrifugation at 2000 rpm for 10 min. The
resulting organic layer was transferred into and HPLC vial, evapo-
rated under nitrogen current and reconstituted in 100 mL of hy-
droxylamine solution (100 mM in 50% methanol (v/v)) and heated
at 60 C for 1 h before being injected (10 mL) into the UPLC-MS/MS
system.
Calibration curve was prepared by substituting the plasma with
4% of BSA solution (2 g of BSA in 50 mL of DPBS). Thus, working
solutions of mix steroids (P5, d4-P5, P4, d9-P4, 17P4, d8-17P4, 17P5,
AD, T, d3-T) dissolved in methanol were added to the BSA solution,
before being extracted twice with 1 mL of MTBE, evaporated under
nitrogen and reconstituted in hydroxylamine solution (heated at
60 C for 1 h). The calibration curve consisted of ten concentration
levels: 0.01, 0.025, 0.05, 0.1, 0.25, 0.5, 1, 2.5, 5, 10 ppb, a zero sample
(only IS added, to calculate extraction efﬁciency), and a blank (no
standards added).
Samples were analysed by an UPLC-MS/MS system (Ultra Acq-
uity LC System, TQ Detector, Waters, USA), with a Zorbax Eclipse
Plus C-18 column (2.1mm 50mm,1.8 mm) (Agilent, Loveland, U.S)
connected to a pre-column Zorbax Eclipse Plus C-18
(2.1 mm  5 mm, 1.8 mm) (Agilent, Loveland, U.S). Steroids (T, d3-T,
AD, P4, d9-P4, P5, d4-P5, 17P4, d8-17P4 and 17P5) were detected
under positive electrospray ionization (ESþ) and multiple reaction
mode (MRM), measuring the transition of precursor ion fragmen-
tation to product ions under a capillary voltage of 3.00 Kv and cone
voltage of 34 V (see Table 1). The mobile phase consisted of
methanol (A) and Milli-Q water (B) both containing 0.1% (v/v) of
formic acid. The runwas as follows: 0.1 min at 10% A, a 2 min linear
gradient from 10% A to 70% A, a 3 min linear gradient from 70% A to
90% A, 2 min at 90% A and back to initial conditions at 1 min,
allowing 2 min for column re-equilibration. The total run-time was
10 min at a ﬂow rate of 0.2 mL/min. The columnwas maintained at
48 C. The limit of detection was <50 ng/L for all steroids, with the
exception of P5< 10 ng/L. Deuterated steroids added to the samples
in order to compensate for matrix effects and to evaluate the efﬁ-
ciency of the extractionprocedure, showed recoveries of 79 ± 9% forTable 1
Masses of precursor and product ions of steroids detected in plasma by UPLC-MS/MS, ob
dissociation with multiple reaction monitoring (MRM).
Precursor ion (m/z) Product
Androstenedione 317 112; 124
Testosterone 304 112; 124
d3-Testosterone 307 112; 124
Progesterone 345 112; 124
d9-Progesterone 354 115; 128
Pregnenolone 332 86; 60
d4-Pregnenolone 336 90
17a-Hydroxyprogesterone 361 112; 124
d8-17a-Hydroxyprogesterone 369 115; 128
17a-Hydroxypregnenolone 348 330; 312d3-T, 68 ± 14% for d4-P5, 97 ± 11% for d8-17P4 and 84 ± 22% for d9-
P4 (n ¼ 20).
2.5. Histological analysis
Histological analyses were performed in order to unequivocally
assess the sex of the ﬁsh used in the study since visual classiﬁcation
was not possible due to the low degree of sexual development of
the gonads. With this purpose, portions of gonadal tissues were
ﬁxed in 4% PAF at 4 C overnight. Fixed gonads were dehydrated
using a graded series of ethanol concentrations (70e100%) and
embedded in paraplast (Leica, Germany). Sections for histological
examination were cut at 5 mm on a retracting microtome and
stained with haematoxylin and eosin.
2.6. RNA isolation, cDNA synthesis and qRT-PCR
Total RNA from gonads of control and DRO-exposed groups after
2 and 31 days of treatment was isolated with TRIZOL (Invitrogen,
Paisley, UK) following the manufacturer's instructions. The con-
centration and quality of the RNA was assessed by spectropho-
tometry and gel electrophoresis. Total RNA (2 mg) was reverse
transcribed to cDNAwith Superscript III (200 units; Invitrogen) and
random hexamer primer (50 mM) following the manufacturer's
instructions. The resulting cDNAs were used as a template to
amplify and quantify the expression levels of cyp17a1, cyp19a and
cyp11b genes. Previously, A TBLASTN search (Altschul et al., 1997)
was conducted to identify the cyp17a1 sequence in the European
sea bass genome database (Tine et al., 2014), using as queries
various known vertebrate sequences. Once identiﬁed, speciﬁc
primers were designed for its complete ampliﬁcation. Full CDS
sequence was cloned and sequenced in order to verify its identity
when compared with the sea bass genome. The veriﬁed and cloned
sequence was ﬁnally deposited in the GenBank database under the
accession number KT932710. Full sequences for sea bass cyp19a1a
and cyp11beta were available in the GenBank under accession
numbers AJ318516 and AF449173, respectively. Speciﬁc primers for
detecting housekeeping and target genes were designed using
primer 3 software (http://www.bioinformatics.nl//cgi-bin/
primer3plus/primer3plus.cgi) and examined for their speciﬁcity
and ampliﬁcation efﬁciency using serial dilutions of template
(Table 2). The melting curve analysis (60 C for 15 s and 95 C for
15 s) after the ampliﬁcation phase displayed a single peak for every
gene, ensuring primers speciﬁcity. Moreover, PCR efﬁciencies (E) of
all primers ranged between 90% and 110%. All qRT-PCR reactions
were analysed on 7300 Real Time PCR System (Applied Biosystems)
using SYBRGreen (Select MasterMix, Applied Biosystems). Samples
were run in triplicate in 96-well plates in a 15 mL reaction, con-
taining 7.5 mL of SYBR Green, 0.75 mL of each of forward and reverse
primer, 1 mL of cDNA sample and 5 mL nuclease-free water. The qRT-tained under positive electrospray ionization (ESþ) subsequent to collision induced
ion (m/z) Fragmentor voltage (V) Collision energy (eV)
40 30; 30
50 30; 30
40 30; 30
40 30; 30
50 30; 30
40 25; 25
40 30
40 30; 30
50 35; 35
10 10; 20
Table 2
Primer sequences and variables used for the ampliﬁcation and calculation of the efﬁciency (E) of the real-time qPCR reactions.
Gene Primer sequence (50/30) Slope E R2 Amplicon size (bp)
cyp17a1 Sense: TTGCAGGAAGACCCAGAACT
Antisense: TCTCCAAACATGCACAGAGC
2.92 2.20 0.97 133
cyp19a1a Sense: AGACAGCAGCCCAGGAGTTG
Antisense: TGCAGTGAAGTTGATGTCCAGTT
3.33 1.99 0.99 106
cyp11b Sense: CTGGAAGCCAGTTGCCATGT
Antisense: TCCTCCACTGCCCAAATAA
3.33 1.99 0.99 98
18S Sense: GCATGCCGGAGTCTCGTT
Antisense: TGCATGGCCGTTCTTAGTTG
3.33 1.99 0.99 70
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activation step for 10 min at 95 C, followed by 40 cycles of 15 s
denaturation at 95 C and a 1 min annealing/extension step at
60 C. Finally, a dissociation step of 15 s at 95 C followed by 15 s at
60 C was added. The 18s rRNA was selected as reference gene for
normalization due to its stable expression among the solvent
control and treated groups. Datawere collected and compiled using
SDS 2.3 software (Applied Biosystems) that was used to calculate
gene expression levels. For each gene, a non-template control was
included to conﬁrm the absence of DNA contamination. In addition,
the same control sample was used in all runs to calculate the intra-
and inter-assay variations. Control values were adjusted for differ-
ences in E of each primer set using Q-gene. Values were normalized
(normalized expression; NE) to the reference gene following the
equation NE ¼ (Eref)Ctref/(Etarget)Cttarget. Replicates were averaged
and shown as mean normalized expression (MNE) ± SEM.2.7. Biochemical determinations
Hepatic microsomal fractions were prepared as described in
Fernandes et al. (2013). Livers (0.5 g) were ﬂushed with ice-cold
1.15% KCl and homogenized in 1:4 w/v cold homogenization
buffer containing 100 mM KH₂PO₄/K₂HPO₄ buffer pH 7.4, 150 mM
KCl, 1 mM dithiothreitol (DTT), 1 mM ethylenediaminetetraacetic
acid (EDTA) and 0.1 mM phenylmethylsulfonylﬂuoride (PMSF).
Homogenates were centrifuged at 500  g for 15 min, and the
obtained supernatant centrifuged at 12,000  g for 45 min. The
resulting supernatant was further centrifuged at 100,000  g for
60 min to obtain the microsomal fraction. Microsomal pellets were
resuspended in a ratio of 0.5 mL buffer/g of liver in 100 mM
potassiumephosphate buffer pH 7.4, containing 150 mM KCl, 20%
(w/v) glycerol, 1 mM DTT, 0.1 mM PMSF and 1 mM EDTA. Proteins
were measured according to the method of Bradford (1976), using
BSA as standard.
EROD activity was determined in the microsomal fraction of the
liver and was assayed by incubating 0.1 mg of protein with 3.7 mM
of 7-ethoxyresoruﬁn and 225 mM of NADPH in 100 mM KH₂PO₄/
K₂HPO₄ buffer pH 7.4 (ﬁnal volume of 250 mL) at 30 C for 10 min.
The reaction was stopped by adding 400 mL of ice-cold acetonitrile
and after centrifugation (2000  g; 10 min) an aliquot of the su-
pernatant (200 mL) was transferred into a 96-multiwell plate.
Fluorescence was read at the excitation/emission wavelength pairs
of 537/583 using a Varioskan microplate reader (Thermo Electron
Corporation). Quantiﬁcation was performed using a 7-
hydroxyresoruﬁn calibration curve and the activity calculated as
the amount of 7-hydroxyresoruﬁn (pmol) generated per milligram
of protein per minute.
BFCOD activity was analysed according to the procedure
described by Thibaut et al. (2006). The assay consisted in incubating
25 mg of liver microsomal protein with 200 mM of 7-benzyloxy-4-
triﬂuoromethyl-coumarin (BFC) and 22.5 mM of NADPH in
100 mM potassium phosphate buffer pH 7.4 (ﬁnal volume of250 mL) at 30 C for 10 min. The reactionwas stopped by addition of
75 mL of acetonitrile (20:80, v/v), the ﬂuorescence was read in a
200 mL aliquot transferred into a 96-multiwell plate at the excita-
tion/emission wavelength pairs of 409 and 530 nm, using a Vari-
oskan microplate reader (Thermo Electron Corporation), and the
activity calculated as the amount of 7-hydroxy-4-(triﬂuoromethyl)-
coumarin (pmol) generated per milligram of protein per minute.
UDP-glucuronosyltransferase activity (UGT) was determined in
hepatic microsomal fraction and was assayed by incubating
0.25 mg of proteins (pre-treated for 15 min with 0.2% Triton X-100
on ice) with 3.0 mM of UDPGA in 50 mM Tris-HCl buffer pH 7.4,
containing 10 mMMgCl2 (ﬁnal volume of 260 mL). The reactionwas
initiated by the addition of 81 mM p-nitrophenol (pNP) and run for
30 min at 30 C in a shaking water bath. The reaction was stopped
by the addition of 0.2 M ice-cold trichloracetic acid (TCA), centri-
fuged (1500  g; 15 min), alkalinized with 0.1 mL of 10 N KOH and
the remaining pNP was measured spectrophotometrically at
405 nm. Activity was calculated as the amount of pNP (nmol)
consumed per milligram of protein per minute.2.8. Statistical analysis
Plasma steroid levels were determined in pooled samples of two
individuals. Enzymatic activities were determined in duplicate in
six individual ﬁsh per tank. Comparisons between treatment
groups were made using one-way ANOVA followed by multiple
independent group comparison (Dunnett and Tukey's test). DRO
levels in plasma were analysed by non-parametric Kruskal-Wallis
test. RNA gene expressionwas determined in six individual ﬁsh per
treatment and results were expressed as mean normalised
expression (MNE) ± SEM and analysed by non-parametric Mann-
Whitney test comparing results between control and exposed
groups.
In all instances transformations of the data were performed
when the assumption of normality of residuals was not met. All
statistical analyses were performedwith the software package SPSS
15.0 (SPSS Inc., Chicago, IL) and p values lower than 0.05 were
considered statistically signiﬁcant.3. Results
3.1. Biological parameters and histological examination of the
gonads
The morphometric parameters of the ﬁsh are presented in
Table 3. Individuals were rather similar in body weight, length and
condition factor (CF) and no signiﬁcant differences were observed
among the different groups. In addition, histological examination of
the gonads revealed no effects of DRO in treated ﬁsh at any con-
centration and exposure length.
Table 3
Biological parameters of sea bass (Dicentrarchus labrax). Values are mean ± SEM (n ¼ 5e9). Condition factor (CF) was calculated as (weight/length3)  100.
Exposure time Concentration Length (cm) Weight (g) Condition factor (g/cm3)
2 days Control (C) 13.7 ± 1.1 35.8 ± 3.6 1.5 ± 0.5
Solvent control (SC) 13.4 ± 0.5 32.0 ± 5.2 1.4 ± 0.7
0.01 mg/g 12.5 ± 0.6 36.3 ± 7.8 1.7 ± 0.2
0.1 mg/g 12.4 ± 0.7 32.0 ± 5.2 1.6 ± 0.1
1 mg/g 12.0 ± 0.3 32.7 ± 2.5 1.9 ± 0.2
10 mg/g 10.8 ± 1 30.5 ± 3.6 1.8 ± 0.3
4 days Control (C) 12.9 ± 0.4 34.5 ± 2.4 1.6 ± 0.04
Solvent control (SC) 12.8 ± 0.5 34.4 ± 4.4 1.6 ± 0.05
0.01 mg/g 12.9 ± 0.4 38.3 ± 4.0 1.7 ± 0.03
0.1 mg/g 12.7 ± 0.3 35.4 ± 2.2 1.7 ± 0.04
1 mg/g 12.0 ± 0.4 29.3 ± 2.9 1.7 ± 0.08
10 mg/g 12.6 ± 0.6 36.4 ± 5.0 1.8 ± 0.03
8 days Control (C) 12.2 ± 0.2 29.1 ± 1.9 1.6 ± 0.04
Solvent control (SC) 12.7 ± 0.4 34.0 ± 3.7 1.6 ± 0.05
0.01 mg/g 12.5 ± 0.5 36.6 ± 3.6 1.9 ± 0.09
0.1 mg/g 13.0 ± 0.2 38.4 ± 1.4 1.8 ± 0.06
1 mg/g 12.9 ± 0.2 36.5 ± 1.6 1.7 ± 0.02
10 mg/g 12.9 ± 0.4 36.4 ± 3.6 1.7 ± 0.04
16 days Control (C) 12.5 ± 0.6 34.9 ± 5.3 1.7 ± 0.02
Solvent control (SC) 12.4 ± 0.4 32.4 ± 3.7 1.7 ± 0.05
0.01 mg/g 15.6 ± 0.5 33.0 ± 3.4 1.6 ± 0.04
0.1 mg/g 12.0 ± 0.6 30.9 ± 4.2 1.8 ± 0.04
1 mg/g 12.8 ± 0.5 38.4 ± 5.1 1.8 ± 0.07
10 mg/g 13.8 ± 0.6 45.5 ± 6.2 1.7 ± 0.07
31 days Control (C) 12.4 ± 0.5 31.6 ± 3.7 1.6 ± 0.15
Solvent control (SC) 12.1 ± 0.5 31.2 ± 5.2 1.7 ± 0.2
0.01 mg/g 13.3 ± 0.3 38.7 ± 2.7 1.6 ± 0.03
0.1 mg/g 13.3 ± 0.6 40.4 ± 4.7 1.7 ± 0.08
1 mg/g 13.0 ± 0.5 35.4 ± 3.9 1.6 ± 0.1
10 mg/g 13.4 ± 0.5 40.8 ± 5.1 1.6 ± 0.15
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DRO, in the range of 4e27 ng/mL, was detected circulating in
plasma of individuals exposed to 10 mg DRO/g food (Fig. 1). The
highest concentration was detected after four days of exposure and
the lowest at 31 days. Levels of DRO in plasma of individuals
exposed to 0.01e1 mg DRO/g were below the detection limit of the
method (1 ng/mL).3.3. Steroids in plasma
Steroids were analysed in the plasma of individuals exposed to
DRO for 4 and 31 days. No signiﬁcant differences in plasma steroid
levels were observed between exposed and control groups after 4
days of treatment (Fig. 2). However, levels of 17P5 (up to 7-fold),
17P4 (up to 3-fold) and AD (up to 2-fold) were signiﬁcantly
increased in individuals exposed to the lowest concentration ofa
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Fig. 1. Drospirenone concentrations in plasma of sea bass (Dicentrarchus labrax) after
exposure to pellet feed contaminated with 10 mg/g of DRO. Values are mean ± SEM
(n ¼ 5e6). Distinct letters indicate signiﬁcant differences between exposure days.DRO (0.01 mg DRO/g food) for 31 days, while no changes were
observed for P5, P4 and T (Fig. 2). Exposure to higher concentra-
tions of DRO (0.1, 1 and 10 mg DRO/g food) did not signiﬁcantly alter
circulating steroid levels in juvenile sea bass.3.4. RNA gene expression
Data from control and exposed ﬁsh, regardless of exposure
concentration, were pooled for the analysis in order to obtain a
statistically robust sample size that could take into consideration
males and females as separate variables. This is particularly
important considering that the expression levels of the genes
cyp19a1a and cyp11beta exhibit sex-related differences (Blazquez
et al., 2009). After 2 days of DRO administration, a signiﬁcant 2-
fold induction of cyp17a1 was detected in the ovaries of exposed
females (Fig. 3). Expression of cyp17a1was one order of magnitude
higher in male gonads, and it was not altered by exposure. Neither
cyp19a1a nor cyp11b expression were altered by DRO treatment.
After 31 days of dietary exposure to DRO, no differences in the
expression of cyp17a1, cyp19a1a or cyp11b were observed between
control and treated ﬁsh (Fig. 3).3.5. Hepatic metabolism
DRO had no signiﬁcant effect in the activity of EROD, BFCOD or
UGTafter 2 or 31 days of treatment (Fig. 4). Nonetheless, a tendency
towards lower EROD and UGTactivities was detected after 2 days of
exposure to 0.1 mg DRO/g food. EROD activity ranged from 32 to
59 pmol/min/mg protein at 2 days of exposure, while after 31 days
of exposure the variability among tanks was smaller (31e43 pmol/
min/mg protein). A similar tendency was observed for UGT.
EROD, BFCOD and UGT activities were also determined after 8
days of exposure, and no statistically signiﬁcant differences were
detected among treatments (data no shown).
Fig. 3. Mean normalised expression (MNE ± SEM) of cyp17a1, cyp19a1a and cyp11b
genes in gonads of sea bass (Dicentrarchus labrax) exposed for 2 and 31 days to DRO.
*Signiﬁcant differences relative to the control (P < 0.05). Data from the different
exposure concentrations (n ¼ 13 males, 7 females) and from control groups (n ¼ 4
males, 6 females) were pooled.
Fig. 2. Plasma steroid levels after 4 and 31 days of exposure. Values are mean ± SEM
(n ¼ pools of 2 individuals). P5: pregnenolone; 17P5: 17a-hydroxypregnenolone; P4:
progesterone; 17P4: 17a-hydroxyprogesterone; AD: androstenedione; T: testosterone.
Results of control samples are shown as mean of control and solvent control. *Sig-
niﬁcant differences relative to the control (P < 0.05).
M. Blanco et al. / Environmental Pollution 213 (2016) 541e5485464. Discussion
The detection of DRO in plasma of sea bass after 2, 4, 8, 16 and 31
days of exposure conﬁrms the uptake of the compound and its
distribution in the body. Considering a daily intake of 0.7 g food
pellets/ﬁsh, the concentration of DRO detected in plasma repre-
sents only 0.06e0.4% of the amount theoretically ingested daily. If
we assume that, as in humans, the absolute bioavailability of DRO
after oral administration is of 76% and that approximately 95e97%
of the compound binds to serum proteins (Krattenmacher, 2000), a
maximum of 160 ng DRO/mL would be expected in the plasma of
sea bass exposed to 10 mg/g. However, the maximum plasmatic
concentration detected was 27 ng/mL after four days of exposure,
and decreased to 5 ng/mL after 31 days. Certainly, some desorption
of DRO from food might occur while in water, prior to beingingested, although food was eaten within 5 min. Altogether, the
results indicate no signiﬁcant bioconcentration of DRO in plasma
over time and suggest that the compound is metabolized by juve-
nile sea bass. Similarly, DRO was reported to have a relatively low
bioconcentration factor (BCF: 36) in mussels after 2 weeks of
exposure to 100 mg DRO/L; concentrations were below detection
limit for those mussels exposed to 0.01 mg/L (Gilroy et al., 2014).
However, despite the evidence of a metabolism of DRO in juvenile
sea bass, CYP1A, CYP3A and UGT activities determined in liver
microsomal fractions were not signiﬁcantly altered by exposure,
suggesting that the metabolism of DRO was probably CYP-
independent. In humans, DRO is mainly metabolized in the liver
to 4,5-dihydrodrospirenone-3-sulfate and to the acid form that is
generated by opening of the lactone ring, both metabolites are re-
ported not to be pharmacologically active and are CYP-independent
(Krattenmacher, 2000). Nonetheless, it has been reported that DRO
is metabolized to a minor extent (4e7%) by CYP3A4 in human liver
microsomes, and an inhibition of CYP3A4 can moderately increase
DRO exposure in individuals treated with DRO, suggesting a po-
tential involvement of the enzyme in DRO metabolism (FDA, 2006;
Wiesinger et al., 2015).
No signiﬁcant changes in length, weight and condition factor
were observed in sea bass regardless of the concentration or
exposure length. Similarly, Zucchi et al. (2014) reported no signif-
icant morphometric changes in zebraﬁsh (Danio rerio) exposed up
to 5 mg/L DRO for 14 days, despite a signiﬁcant decrease in the
gonadosomatic index (GSI), strong inhibition of VTG mRNA and
altered transcription of cyp19a1a. In the present work, the
expression of cyp19a1a and cyp11b in gonads of juvenile sea bass
was not altered by exposure, but a 2-fold up-regulation of cyp17a1
was detected in ovaries of exposed females. Cyp17a1 encodes for a
protein that has both 17a-hydroxylase and 17,20-lyase activities
and catalyzes the conversion of pregnenolone and progesterone to
their 17a-hydroxylated products, and subsequently to dehydro-
epiandrosterone (DHEA) and androstenedione. Although our ﬁnd-
ings should be interpreted with caution, as females from all
exposure concentrations were pooled, it is interesting to notice that
Fig. 4. EROD (CYP1A), BFCOD (CYP3A) and UDP-glucuronosyltransferase (UGT) activ-
ities determined in liver microsomal fractions of juvenile sea bass exposed for 2 and 31
days to different concentrations of DRO (0.01, 0.1, 1 and 10 mg/g of pellet feed). Values
are mean ± SEM (n ¼ 6).
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plasmatic levels of 17P4, 17P5 and AD were detected in sea bass
exposed to 0.01 mg DRO/g food for 31 days, while T levels were not
altered (Fig. 2). Similarly, Runnalls et al. (2013) reported no effect of
DRO in plasmatic concentrations of T and 11-ketotestosterone after
31 days of exposure in males of fathead minnow. Neither Zeilinger
et al. (2009) observed masculinization of female fathead minnow
exposed to DRO (70 mg/L). Altogether, these ﬁndings are in agree-
ment with the fact that DRO is not an agonist of ﬁsh androgen re-
ceptors (ARa and ARb), but a weak agonist of the progesterone
receptor (Ellestad et al., 2014; Bain et al., 2015), and as such, it
might have progesterone-like action at relatively low
concentrations.
The analysis of pharmaceuticals in ﬁsh plasma can be an
excellent tool to assess the risk for pharmacological effects, as
plasma concentrations can be easily compared with human ther-
apeutic levels (Fick et al., 2010). Thus, concentrations of levonor-
gestrel of 2.4 ng/L were enough to bioaccumulate in plasma of
rainbow trout at levels exceeding up to 4 times the human thera-
peutic dose. Nevertheless, in the present study, only sea bass from
the high exposure group had plasmatic concentrations of DRO
(5e27 ng/mL) relatively close to human therapeutic concentrations
(20e25 ng/mL; maximum 60e87 ng/mL). Nonetheless, ﬁsh from
the low exposure group, with plasmatic concentrations well belowhuman therapeutic doses, showed increased plasmatic levels of
17P4, 17P5 and AD after 31 days exposure. These results, together
with the increased expression of cyp17a1 in females, evidence the
ability of DRO to alter steroid synthesis in juvenile sea bass with a
mean uptake of 7 ng DRO/day (10 ng/g  0.7 g food/day). However,
the consequences in terms of impaired gonad development and/or
reproduction in adult sea bass remain unknown.
Overall, the work contributes to the better understanding of the
impact of DRO in ﬁsh. The question on whether environmental
concentrations of DRO are likely to have an endocrine effect in ﬁsh
still remain open, as so far, concentrations of DRO in water are
unknown and it is uncertain whether the uptake of DRO through
thewater will have the same endocrine disruptive effect as through
the food. However, this work (a) evidences the ability of DRO to
increase plasmatic levels of 17P5, 17P4 and AD in juvenile sea bass
and to increase the expression of cyp17a1 in ovaries after a daily
intake of 7 ng DRO for up to 31 days, and (b) stresses the need of
performing further exposure experiments at the low ng/L concen-
tration range to ascertain whether the same endocrine disruptive
effect is likely to occur at environmentally relevant concentrations
of DRO.
Acknowledgments
Maria Blanco acknowledges a pre-doctoral fellowship (FPI, BES-
2012-054438) from the Spanish Government and Paula Medina the
pre-doctoral fellowship MECE2, ANT0806. Denise Fernandes ac-
knowledges a post-doctoral fellowship (SFRH/BPD/34289/2006)
from the Portuguese Fundaç~ao para a Cie^ncia e Tecnologia (FCT) of
the Ministry of Science and Technology of Portugal. This study was
supported by the Spanish National Plan of Research (Project
Ref. CGL2011-24538).
References
Altschul, S.F., Madden, T.L., Sch€affer, A.A., Zhang, J., Zhang, Z., Miller, W., Lipman, D.J.,
1997. Gapped BLAST and PSI-BLAST: a new generation of protein database
search programs. Nucleic Acids Res. 25, 3389e3402.
Bain, P.A., Kumar, A., Ogino, Y., Iguchi, T., 2015. Nortestosterone-derived synthetic
progestogens do not activate the progestogen receptor of MurrayeDarling
rainbowﬁsh (Melanotaenia ﬂuviatilis) but are potent agonists of androgen re-
ceptors alpha and beta. Aquat. Toxicol. 163, 97e101.
Besse, J.-P., Garric, J., 2009. Progestagens for human use, exposure and hazard
assessment for the aquatic environment. Environ. Pollut. 157, 3485e3494.
Blazquez, M., Piferrer, F., Zanuy, S., Carrillo, M., Donaldson, E.M., 1995. Development
of sex control techniques for European sea bass (Dicentrarchus labrax L.)
aquaculture: effects of dietary 17a-methyltestosterone prior to sex differenti-
ation. Aquaculture 135, 329e342.
Blazquez, M., Zanuy, S., Carrillo, M., Piferrer, F., 1998. Structural and functional ef-
fects of early exposure to estradiol-17b and 17a-ethynylestradiol on the gonads
of the gonochoristic teleost Dicentrarchus labrax. Fish Physiol. Biochem. 18,
37e47.
Blazquez, M., Felip, A., Zanuy, S., Carrillo, M., Piferrer, F., 2001. Critical period of
androgen-inducible sex differentiation in a teleost ﬁsh, the European sea bass.
J. Fish Biol. 58, 342e358.
Blazquez, M., Navarro-Martín, L., Piferrer, F., 2009. Expression proﬁles of sex
differentiation-related genes during ontogenesis in the European sea bass
acclimated to two different temperatures. J. Exp. Zool. 312B, 686e700.
Bradford, M., 1976. A rapid and sensitive method for the quantiﬁcation of micro-
gram quantities of protein utilizing the principle of protein-dye binding. Anal.
Biochem. 72, 248e254.
Ellestad, L., Cardon, M., Chambers, I., Farmer, J., Harting, P., Stevens, K.,
Villenueve, D., Wilson, V., Orlando, E., 2014. Environmental gestagens activate
fathead minnow (Pinephales promelas) nuclear progesterone and androgen re-
ceptors in vitro. Environ. Sci. Technol. 48, 8179e8187.
FDA, 2006. US Food and Drug Administration, Center for Drug Evaluation and
Research: NDA 21676 e Clinical pharmacology and biopharmaceutics review(s).
www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021676s000_
CLINPHARMR.pdf (last accessed 21.08.15.).
Fent, K., 2015. Progestins as endocrine disrupters in aquatic ecosystems: concen-
trations, effects and risk assessment. Environ. Int. 84, 115e130.
Fernandes, D., Dimastrogiovanni, G., Blazquez, M., Porte, C., 2013. Metabolism of the
polycyclic musk galaxolide and its interference with endogenous and xenobi-
otic metabolizing enzymes in the European sea bass (Dicentrarchus labrax).
M. Blanco et al. / Environmental Pollution 213 (2016) 541e548548Environ. Pollut. 174, 214e221.
Fernandes, D., Pujol, S., Ace~na, J., Perez, S., Barcelo, D., Porte, C., 2014. The in-vitro
interference of synthetic progestogens with carp steroidogenic enzymes.
Aquat. Toxicol. 155, 314e321.
Fick, J., Lindberg, R.H., Parkkonen, J., Arvidsson, B., Tysklind, M., Larsson, D.G.J., 2010.
Therapeutic levels of levonorgestrel detected in blood plasma of ﬁsh: results
from screening rainbow trout exposed to treated sewage efﬂuents. Environ. Sci.
Technol. 44, 2661e2666.
Gilroy, E.A.M., Klinck, J.S., Campbell, S.D., McInnis, R., Gillis, P.L., de Solla, S.R., 2014.
Toxicity and bioconcentration of the pharmaceuticals moxiﬂoxacin, rosuvasta-
tin, and drospirenone to the unionid mussel Lampsilis siliquoidea. Sci. Total
Environ. 487, 537e544.
Keski-Rahkonen, P., Huhtinen, K., Poutanen, M., Auriola, S., 2011. Fast and sensitive
liquid chromatography-mass spectrometry assay for seven androgenic and
progestagenic steroids in human serum. J. Steroid Biochem. Mol. Biol. 127,
396e404.
Krattenmacher, R., 2000. Drospirenone: pharmacology and pharmacokinetics of a
unique progestogen. Contraception 62, 29e38.
Kumar, V., Johnson, A.C., Trubiroha, A., Tumova, J., Ihara, M., Grabic, R., Kloas, W.,
Tanaka, H., Kroupova, H.K., 2015. The challenge presented by progestins in
ecotoxicological research: a critical review. Environ. Sci. Technol. 49,
2625e2638.
Nagahama, Y., Yamashita, M., 2008. Regulation of oocyte maturation in ﬁsh. Dev.
Growth Differ. 50, S195eS219.
Overturf, M.D., Overturf, C.L., Carty, D.R., Hala, D., Huggett, D.B., 2014. Levonorges-
trel exposure to fathead minnows (Pinephales promelas) alters survival, growth,
steroidogenic gene expression and hormone production. Aquat. Toxicol. 148,
152e161.
Paulos, P., Runnalls, T.J., Nallani, G., La Point, T., Scott, A.P., Sumpter, J.P.,
Huggett, D.B., 2010. Reproductive responses in fathead minnow and Japanese
medaka following exposure to a synthetic progestin, Norethindrone. Aquat.
Toxicol. 99, 256e262.
Petersen, L.H., Hala, D., Carty, D., Cantu, M., Martinovic, D., Huggett, D.B., 2015. Ef-
fects of progesterone and norethindrone on female fathead minnow (Pime-
phales promelas) steroidegenesis. Environ. Toxicol. Chem. 34, 379e390.
Piferrer, F., Blazquez, M., Navarro, L., Gonzalez, A., 2005. Genetic, endocrine, andenvironmental components of sex determination and differentiation in the
European sea bass (Dicentrarchus labrax L.). Gen. Comp. Endocrinol. 142,
102e110.
Rapkin, A.J., Winer, S.A., 2007. Drospirenone: a novel progestin. Drug evaluation,
expert opinion. Pharmacotherapy 8 (7), 989e999.
Runnalls, T.J., Beresford, N., Losty, E., Scott, A.P., Sumpter, J.P., 2013. Several synthetic
progestins with different potencies adversely affect reproduction of ﬁsh. En-
viron. Sci. Technol. 47, 2077e2084.
Scott, A.P., Sumpter, J.P., Stacey, N., 2010. The role of the maturation-inducing steroid
17,20b-dihydroxypregn-4-en-3-one, in male ﬁshes: a review. J. Fish Biol. 76,
183e224.
Svensson, J., Fick, J., Brandt, I., Brunstr€om, B., 2014. Environmental concentrations of
an androgenic progestin disrupts the seasonal breeding cycle in male three-
spined stickleback. Aquat. Toxicol. 147, 84e91.
Thibaut, R., Schnell, S., Porte, C., 2006. The interference of pharmaceuticals with
endogenous and xenobiotic metabolizing enzymes in carp liver: an in-vitro
study. Environ. Sci. Technol. 40, 5154e5160.
Tine, M., Kuhl, H., Gagnaire, P.A., Louro, B., Desmarais, E., Martins, R., Hecht, J.,
Knaust, F., Belkhir, K., Klages, S., Dieterich, R., Stueber, K., Piferrer, F., Guinand, B.,
Bieme, N., Volckaert, F.A.M., Bargelloni, L., Power, D.M., Bonhomme, F.,
Canario, A.V.M., Reindhart, R., 2014. European sea bass genome and its variation
provide insights into adaptation to euryhalinity and speciation. Nat. Commun.
5, 5770. http://dx.doi.org/10.1038/ncomms6770.
Wiesinger, H., Berse, M., Klein, S., Gschwend, S., H€ochel, J., Zollmann, F.S., Schütt, B.,
2015. Pharmacokinetic interaction between the CYP3A4 inhibitor ketoconazole
and the hormone drospirenone in combination with ethinylestradiol or estra-
diol. Br. J. Clin. Pharmacol. http://dx.doi.org/10.1111/bcp.12745. In Press.
Zeilinger, J., Steger-Hartmann, T., Maser, E., Goller, S., Vonk, R., L€ange, R., 2009. Ef-
fects of synthetic gestagens on ﬁsh reproduction. Environ. Toxicol. Chem. 28,
2663e2670.
Zhao, Y.B., Castiglioni, S., Fent, K., 2015. Environmental progestins progesterone and
drospirenone alter the circadian rhythm network in zebraﬁsh (Danio rerio).
Environ. Sci. Technol. 49, 10155e10164.
Zucchi, S., Mirbahai, L., Castiglioni, S., Fent, K., 2014. Transcriptional and physio-
logical responses induced by binary mixtures of drospirenone and progesterone
in zebraﬁsh (Danio rerio). Environ. Sci. Technol. 48, 3523e3531.
